Canadian surgical imaging technology developer Perimeter Medical Imaging has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its optical tissue imaging system (OTIS).
Based on optical coherence tomography, OTIS can perform real-time imaging of the periphery of excised tissue, offering visualization of subsurface structures up to 2 mm below the surface, Perimeter said. Surgical centers in Canada and the U.S. are planning to deploy OTIS in a large clinical adoption study that is expected to launch at the end of 2016, according to the company.
